Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 4/20 | 0.44 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24915343 | 1.00 | ECE1 (0.44) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL992850 | 1.00 | ECE1 (0.44) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL10442189 | 0.88 | ECE1 (0.40) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL12661237 | 0.88 | ECE1 (0.40) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL13233706 | 0.88 | ECE1 (0.40) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL160994 | 0.83 | ECE1 (0.49) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL8729434 | 0.83 | SLC22A6 (0.36) | CA2 | |
| SCHEMBL15866495 | 0.83 | ECE1 (0.37) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL14490960 | 0.83 | SLC22A6 (0.36) | CA2 | |
| SCHEMBL515169 | 0.83 | ECE1 (0.49) | ECE1ITGB2ICAM1ITGALCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2106279-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | Cryobiophysica, Inc. (US) | 2009-10-07 | — | — | EP | claimed |
| US-20080179243-A1 | Stationary Phase Gradient Chromatography | HIRSH ALLEN | 2008-07-31 | — | — | US | claimed |
| WO-2008086357-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | CRYOBIOPHYSICA, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20240219307-A1 | APPARATUS FOR CONDUCTING CONTINUOUS INTERLEAVED ASSAYING IN A MULTI-WELL PLATE | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240159766-A1 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
| US-11940385-B2 | Apparatus for conducting continuous interleaved assaying in a multi-well plate | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-03-26 | — | — | US | disclosed |
| US-11892455-B2 | Assay apparatuses, methods and reagents | MESO SCALE TECHNOLOGIES, LLC. (US) | 2024-02-06 | — | — | US | disclosed |
| EP-1963854-B1 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES LLC (US) | 2021-02-03 | — | — | EP | disclosed |
| US-20210025896-A1 | Assay Apparatuses, Methods and Reagents | MESO SCALE TECHNOLOGIES, LLC. | 2021-01-28 | — | — | US | disclosed |
| US-10794914-B2 | Assay apparatuses, methods and reagents | MESO SCALE TECHNOLOGIES, LLC (US) | 2020-10-06 | — | — | US | disclosed |
| EP-2269026-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | Meso Scale Technologies, LLC (US) | 2011-01-05 | — | — | EP | disclosed |
| US-20090263904-A1 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC | 2009-10-22 | — | — | US | disclosed |
| WO-2009126303-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-2106279-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | Cryobiophysica, Inc. (US) | 2009-10-07 | — | — | EP | disclosed |
| EP-1963854-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | Meso Scale Technologies, LLC (US) | 2008-09-03 | — | — | EP | disclosed |
| US-20080179243-A1 | Stationary Phase Gradient Chromatography | HIRSH ALLEN | 2008-07-31 | — | — | US | disclosed |
| WO-2008086357-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | CRYOBIOPHYSICA, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008057111-A2 | ASSAY APPARATUSES, METHODS AND REAGENTS | MESO SCALE TECHNOLOGIES, LLC (US) | 2008-05-15 | — | — | WO | disclosed |
| US-20070231217-A1 | Assay apparatuses, methods and reagents | UNITED STATES GOVERNMENT; DEFENSE THREAT REDUCTION AGENCY | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | ECE1 1922/4885ITGB2 777/4885ICAM1 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.